Pa. Xarelto Plaintiffs Request to Amend Master Complaint
Pa. Xarelto Plaintiffs Request to Amend Master Complaint
Introduction
More than 1,800 product liability claims involving Johnson & Johnson and its subsidiary Janssen Pharmaceuticals’ blood thinner Xarelto are awaiting trial in Philadelphia Court of Common Pleas, and trials for three Xarelto lawsuits are expected to begin this April.
A request to make changes to the Master Complaint was put before the Philadelphia Court of Common Pleas by the remaining Pennsylvania plaintiffs to give them time to “reorganize the allegations and provide more details about the actions and inactions that form the bases of already-existing causes of action.” This request is strongly opposed by the defendants.
There are nearly 18,000 Xarelto federal product liability claims consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana.
Comments
Latest News
Supreme Court Upholds Flavored Vape Ban
Categories: E-Cigarette: JUUL
The U.S. Supreme Court has unanimously upheld a decision by the Food and Drug Administration (FDA) to block the sale and marketing of certain flavored e-cigarette products.
The ruling supports the FDA’s authority to regulate tobacco…
Judge Rejects JnJ's $10B Talc Lawsuit Settlement
Categories: Talcum
Johnson & Johnson's shares fell more than 5% after a U.S. bankruptcy judge rejected its $10 billion settlement proposal aimed at resolving over 60,000 lawsuits.
These lawsuits allege that the company’s…
Tepezza Hearing Loss MDL: Bellwether Trials Set for 2026
Categories: Tepezza
A U.S. District Judge overseeing Tepezza hearing damage lawsuits nationwide has scheduled four bellwether trials for 2026. These trials are intended to help both parties assess how juries may respond to the evidence and testimonies that could be…